Form 4 for OMDA Omada Health, Inc.
Accepted 2026-07-02 20:04:49 ET · period of report 2026-06-30 · accession 0001610717-26-000320 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-07-02 20:04 | 2026-06-30+ | OMDA | Gracey Craig | CAO | M - OptEx | $6.57 | +1,042 | 16.1K | +7% | +$6,846 |
| DMT | 2026-07-02 20:04 | 2026-06-30+ | OMDA | Gracey Craig | CAO | S - Sale+OE | $22.61 | -1,042 | 15.4K | -6% | -$23.6K |
| DMT | 2026-07-02 20:04 | 2026-06-30+ | OMDA | Gracey Craig | CAO | M - OptEx | $0.00 | -1,042 | 34.4K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-30 | M | A | 405 | $6.57 | 15,846 | D | — | — | |
| 2 | Common | Common Stock | 2026-06-30 | S | D | 405 | $22.00 | 15,441 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. |
| 3 | Common | Common Stock | 2026-07-01 | M | A | 637 | $6.57 | 16,078 | D | — | — | |
| 4 | Common | Common Stock | 2026-07-01 | S | D | 637 | $23.00 | 15,441 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-06-30 | M | D | 405 | $0.00 | 35,012 | D | $6.57 · — to 2034-10-23 | 405 Common Stock | (F2) 25% of the shares subject to the option vest on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |
| 6 | Derivative | Stock Option (Right to Buy) | 2026-07-01 | M | D | 637 | $0.00 | 34,375 | D | $6.57 · — to 2034-10-23 | 637 Common Stock | (F2) 25% of the shares subject to the option vest on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |